Plasminogen Activator Inhibitor 1 (PAI1) Promotes Actin Cytoskeleton Reorganization and Glycolytic Metabolism in Triple Negative Breast Cancer

Molecular Cancer Research - United States
doi 10.1158/1541-7786.mcr-18-0836
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Plasminogen Activator Inhibitor-1 Promotes the Recruitment and Polarization of Macrophages in Cancer

Cell Reports
BiochemistryGeneticsMolecular Biology
2018English

Breast Cancer and Metabolic Syndrome Linked Through the Plasminogen Activator Inhibitor-1 Cycle

BioEssays
BiochemistryGeneticsMolecular Biology
2007English

Metastasis of Transgenic Breast Cancer in Plasminogen Activator Inhibitor-1 Gene-Deficient Mice

Oncogene
Cancer ResearchGeneticsMolecular Biology
2003English

Plasminogen Activator Inhibitor 1 RNAi Suppresses Gastric Cancer Metastasis in Vivo

Cancer Science
Cancer ResearchMedicineOncology
2012English

Retraction: The Effects of Residual Platelets in Plasma on Plasminogen Activator Inhibitor-1 and Plasminogen Activator Inhibitor-1-Related Assays

PLoS ONE
Multidisciplinary
2018English

Coordinated Induction of Plasminogen Activator Inhibitor-1 (PAI-1) and Inhibition of Plasminogen Activator Gene Expression by Hypoxia Promotes Pulmonary Vascular Fibrin Deposition.

Journal of Clinical Investigation
Medicine
1998English

Does Plasminogen Activator Inhibitor-1 Drive Lymphangiogenesis?

PLoS ONE
Multidisciplinary
2010English

Triple-Negative Breast Cancer

2018English

ISL1 Promotes Cancer Progression and Inhibits Cisplatin Sensitivity in Triple-Negative Breast Cancer Cells

International Journal of Molecular Medicine
MedicineGenetics
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy